Risks of miscarriage and inadvertent exposure to artemisinin derivatives in the first trimester of pregnancy: a prospective cohort study in western Kenya

BACKGROUND: The artemisinin anti-malarials are widely deployed as artemisinin-based combination therapy (ACT). However, they are not recommended for uncomplicated malaria during the first trimester because safety data from humans are scarce. METHODS: This was a prospective cohort study of women of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Dellicour, Stephanie, Desai, Meghna, Aol, George, Oneko, Martina, Ouma, Peter, Bigogo, Godfrey, Burton, Deron C., Breiman, Robert F., Hamel, Mary J., Slutsker, Laurence, Feikin, Daniel, Kariuki, Simon, Odhiambo, Frank, Pandit, Jayesh, Laserson, Kayla F., Calip, Greg, Stergachis, Andy, ter Kuile, Feiko O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652370/
https://www.ncbi.nlm.nih.gov/pubmed/26581434
http://dx.doi.org/10.1186/s12936-015-0950-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652370/
https://www.ncbi.nlm.nih.gov/pubmed/26581434
http://dx.doi.org/10.1186/s12936-015-0950-6

Ejemplares similares